ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2013

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

14,500Medicare Part D Prescriptions Filled, Including Refills

Rank: 25 out of 395

$970K Total Retail Price of All Prescriptions

Rank: 7 out of 395

504 Patients Receiving at Least One Drug in Part D
69% Patients 65 Years and Older
58% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg 81928cdb0ebe162ff75cf405bfacadd396bf3ec84bc467b6f3e612dd63daa776 Average for
this specialty
in Nevada
Lower avg 72b1978e1dcc0b845f89d17d692cfff7aeaf8d8bce70310d8bfc535db2daf62a

Schedule Two
Controlled Substances

8% of this provider’s 504 patients filled at least one prescription for a schedule two drug, compared to an average of 7%.

Schedule Three
Controlled Substances

23% of this provider’s 504 patients filled at least one prescription for a schedule three drug, compared to an average of 13%.

Brand Name Drugs

24% of this provider’s prescriptions were for brand-name drugs, compared to an average of 20%.

Prescription Price

$67 was the average price of a prescription from this provider, compared to $53 among peers.

Prescriptions per Patient

29 is the average number of prescriptions (including refills) per patient, compared to an average of 15.


This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

B

A benzodiazepine, or tranquilizer. More » The American Geriatrics Society says these drugs increase the risk of cognitive impairment, delirium, falls and fractures in older adults.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled with Refills Prescriptions
to 65+
Patients Recieving this Drug Category For this Prescriber For All Prescribers in
This Specialty in Nevada
LISINOPRIL 743 469 151 1 1
HYDROCODONE-ACETAMINOPHEN 549 265 104 S3 2 5
PRAVASTATIN SODIUM 526 356 121 3 16
AMLODIPINE BESYLATE 495 391 96 4 4
ATORVASTATIN CALCIUM 483 316 115 5 8
METFORMIN HCL 354 216 79 6 7
OMEPRAZOLE 327 218 69 7 6
GABAPENTIN 314 182 77 8 12
FUROSEMIDE 297 170 66 9 10
LOSARTAN POTASSIUM 266 231 62 10 9
LEVOTHYROXINE SODIUM 263 195 48 11 3
CARVEDILOL 214 120 41 12 23
FAMOTIDINE* 196 106 44 13 70
ATENOLOL 190 134 48 14 15
HYDRALAZINE HCL 179 127 44 15 61
ISOSORBIDE MONONITRATE ER 168 105 40 16 74
SPIRONOLACTONE 168 82 40 16 76
POTASSIUM CHLORIDE 158 103 42 18 22
LOVASTATIN 152 140 34 19 17
TAMSULOSIN HCL 152 124 34 19 24
ZOLPIDEM TARTRATE 146 69 33 21 18
LANTUS SOLOSTAR 145 86 30 22 64
LYRICA 139 50 26 23 129
CLONAZEPAM 137 82 28 B 24 66
BD ULTRA-FINE PEN NEEDLE 136 83 32 25 84
ZETIA 134 89 35 26 95
LISINOPRIL-HYDROCHLOROTHIAZIDE 134 87 28 26 27
OXYCODONE-ACETAMINOPHEN 128 22 12 S2 28 81
ALPRAZOLAM 127 69 31 B 29 14
SIMVASTATIN 123 97 30 30 2
CLOPIDOGREL 122 78 31 31 21
FLUTICASONE PROPIONATE 117 59 42 32 28
CYMBALTA 116 59 25 33 75
CARISOPRODOL 116 30 18 R 33 65
METOCLOPRAMIDE HCL 108 73 12 35 133
ALENDRONATE SODIUM 101 90 24 36 20
IBUPROFEN 101 39 43 36 59
WARFARIN SODIUM 100 29 18 38 19
TRAMADOL HCL 94 68 19 39 30
METOPROLOL TARTRATE 91 64 25 40 11
BACLOFEN 89 44 23 41 77
PREDNISONE 87 62 61 42 67
CITALOPRAM HBR 85 25 15 43 26
LOSARTAN-HYDROCHLOROTHIAZIDE 82 38 18 44 34
ALLOPURINOL 81 51 18 45 29
JANUVIA 80 39 12 46 90
PIOGLITAZONE HCL 79 55 17 R 47 73
FENOFIBRATE* 74 46 18 48 49
NAMENDA 74 74 13 48 45
TRAZODONE HCL 73 41 19 50 41
BYSTOLIC 73 68* 16 50 141
HUMALOG 71 43 17 52 195
CRESTOR 69 32 12 53 53
METOPROLOL SUCCINATE 69 57 14 53 25
DONEPEZIL HCL 68 68 12 55 36
VERAPAMIL ER 68 <11 <11 55 104
HYDROMORPHONE HCL* 68 <11 <11 S2 55 146
CARBIDOPA-LEVODOPA 67 <11 <11 58 144
CLONIDINE HCL 64 59* 13 59 60
MONTELUKAST SODIUM 64 31 15 59 71
FENOFIBRATE* 63 31 15 61 49
TIZANIDINE HCL 63 25 22 61 87
NOVOLOG FLEXPEN 63 39 17 61 124
LOVAZA 58 44 13 64 109
PROAIR HFA 57 13 20 65 63
ONGLYZA 57 <11 <11 65 167
VENTOLIN HFA 57 24 19 65 46
SERTRALINE HCL 54 22 14 68 31
ADVAIR DISKUS 53 13 16 69 50
PANTOPRAZOLE SODIUM 52 40 16 70 35
GLIMEPIRIDE 51 25 17 71 40
OXYCODONE HCL 51 <11 17 S2 71 42
TRADJENTA 51 <11 <11 71 229
DIAZEPAM 51 <11 <11 B 71 68
About This Data

Prescribing data from Medicare’s prescription drug benefit, known as Part D, was compiled and released by the Centers for Medicare and Medicaid Services, the federal agency that oversees the program. ProPublica combined that data with additional information released by CMS. The data for 2013 includes nearly 1.4 billion prescriptions written by 1.3 million doctors, nurses and other providers. This database lists about 410,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths of these prescriptions went to patients 65 and older; the rest were for disabled patients Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to checkup@propublica.org and we will update your information. If you have other questions about this data, send a note to checkup@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on July 9, 2007.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.